Open Beta
TREN
MetriLume
TREN

US marketsRPRX

SEC-sourced researchBeta

RPRX

Royalty Pharma plc

Company comparison ↗

Data passport

CIK
0001802768
Exchange
Nasdaq
Business activity
— · SIC 2834
Financial inputs
6/6
Filing date
Oct 5, 2026
SEC registry record
Operating company
Last updated: SEC company ticker catalog ↗SEC Financial Statement Data Sets ↗SEC investment company series and class registry ↗

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2023: 2,354,554,000.0000 USD; December 2024: 2,263,576,000.0000 USD; December 2025: 2,378,193,000.0000 USD2.4B USD0 USD0December 2023December 2024December 2025
RPRX · Exact amounts and source periods · USD
Period endRevenueFiling date
December 20232,354,554,000.0000Feb 11, 2026
December 20242,263,576,000.0000Feb 11, 2026
December 20252,378,193,000.0000Feb 11, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 20252,378,193,000.0000770,947,000.00002,489,823,000.000019,620,780,000.00009,905,841,000.0000Feb 11, 2026
December 20242,263,576,000.0000858,983,000.00002,768,986,000.000018,222,715,000.00007,880,349,000.0000Feb 11, 2026
December 20232,354,554,000.00001,134,834,000.00002,987,802,000.0000——Feb 11, 2026

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenues$2.38BDecember 2025Feb 11, 202610-K
Previous period revenueRevenues$2.26BDecember 2024Feb 11, 202610-K
Net incomeNetIncomeLoss$770.95MDecember 2025Feb 11, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities$2.49BDecember 2025Feb 11, 202610-K
Total assetsAssets$19.62BDecember 2025Feb 11, 202610-K
Total liabilitiesLiabilities$9.91BDecember 2025Feb 11, 202610-K

New filings

Explore methodology ↗